Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
ORION DIAGNOSTICA OY	02200 ESPOO

International Classification(s)

• G01N:INVESTIGATING OR ANALYSING MATERIALS BY DETERMININ....

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Keränen, Mikko	Tyrnävä, FI	2	1
# of filed Patents : 2 Total Citations : 1
Kololuoma, Terho	Oulu, FI	12	68
# of filed Patents : 12 Total Citations : 68
Luotola, Juhani	Espoo, FI	10	113
# of filed Patents : 10 Total Citations : 113
Sunnari, Antti	Haukipudas, FI	11	106
# of filed Patents : 11 Total Citations : 106

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• G01N Class

• 0 % this patent is cited more than
• 10 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Feb 18, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
August 18, 2015	US,9110027,B2   US9110027B2	GRANTED PATENT AS SECOND PUBLICATION
August 01, 2013	US,20130196444,A1   US20130196444A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9421193

Benzothiazole derivatives and a use thereof for the treatment of cancer

---

Abstract

---

Provided are a compound represented by Formula I, a pharmaceutically acceptable salt thereof, or a solvate thereof; and a pharmaceutical composition for cancer treatment and a pharmaceutical composition for a radiation sensitizer for cancer treatment, each pharmaceutical composition including the compound of Formula I, the pharmaceutically acceptable salt thereof, or the solvate thereof:

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• LAPS2024
• STCH2024
• FP2024
• MAFP2020
• I2016
• STCF2016
• AS2016
• P2015
• F2013
• PD2012

Date	Code	Event	Description
Dec 16, 2024	LAPS	LAPSE FOR FAILURE TO PAY MAINTENANCE FEES	free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY
Dec 16, 2024	STCH	INFORMATION ON STATUS: PATENT DISCONTINUATION	free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362
Nov 08, 2024	FP	LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE	Effective Date: Nov 08, 2024
Apr 21, 2020	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY year of fee payment: 4
Nov 08, 2016	I	Issuance
Oct 19, 2016	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Jul 13, 2016	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WUESTENBECKER, MICHAEL;REEL/FRAME:039147/0123 Owner name: GE SENSING & INSPECTION TECHNOLOGIES GMBH, GERMANY Effective Date: Jul 13, 2016
Nov 19, 2015	P	Published
Dec 18, 2013	F	Filing
Dec 24, 2012	PD	Priority Date